20n
Company

Last deal

$2.1M

Amount

Seed

Stage

01.05.2015

Date

2

all rounds

$2.2M

Total amount

General

About Company
20n engineers microbes using algorithms to produce chemicals with therapeutic and industrial biotech applications.

Industry

Sector :

Subsector :

founded date

01.01.2013

Number of employees

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

The company's open-source biotechnology platform uses data mining technology to enable bioproduction of valuable molecules. They provide computational systems that predict DNA design for novel industrial biotech and health applications, using techniques from machine learning, distributed systems, AI planning, program synthesis, data mining, and natural language processing. Their customers include industrial biotech firms transitioning to sustainable biological processes for advanced fuels, materials, therapeutics, flavors, and fragrances. DARPA supports their work to revolutionize biotech with sequencing, synthesis, and computational systems.
Contacts

Phone number

Website URL

Social url